Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Contracts Finder |
| Notice Type: | Award notice |
| Buyer: | NHS England |
| Main Category: | Goods |
| Procurement Method: | Open procedure (above threshold) |
| Tender Status: | Closed |
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
28 November 2022
Closed
Estimated Value
£264,003,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| Estimated Value (ex. VAT): |
| £264,003,000 |
| Release Date: | 24 March 2023 |
| Application Deadline: | 28 November 2022 |
| Contract Start Date: | 31 March 2023 |
| Contract End Date: | 28 February 2026 |
| Contract Duration: | 3.0 years |
| Procurement ID (OCID): | ocds-b5fd17-f074e643-f848-4b2d-aec8-e624b3fc10e0 |
| Notice Reference: | a6b9f437-01c6-49a7-a10f-e629b7cdf660-627683 |
View Original Notice
Access the full notice on the official portal
Awarded to (6 suppliers)
| Award value: | £264,003,228 |
| Award decision date: | 3 March 2023 |
| Award status: | Active |
Project Title: NHS National Framework Agreement for the supply of Adalimumab Injection 1 April 2023 Offer reference number: CM/PHR/22/5660 CM/PHR/22/5660/01 - NHS Framework Agreement for the supply of Adalimumab Injection to South of England. Period of framework: 1 April 2023 to 31 August 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab Injection to the Midlands and East. Period of framework: 1 April 2023 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/22/5660/03 - NHS Framework Agreement for the supply of Adalimumab Injection to London. Period of framework: 1 April 2023 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/22/5660/04 - NHS Framework Agreement for the supply of Adalimumab Injection to the North of England. Period of framework: 1 April 2023 to 28 February 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
Published contracts in the last 12 months
2,046
total contracts
£179666.3m
total value
£251,986,446
average contract size
Typical categories